Cause of death, by non-communicable diseases, ages 5-14, female in Serbia
Serbia: Cause of death, by non-communicable diseases, ages 5-14, female was 83.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in Serbia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14, female in Serbia is 83.2%, measured in 2021. That is the highest value across all 6 years on record.
The figure is up 16.4% on the previous year and up 1.8% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Serbia peaked at 83.2% in 2021 and was at its lowest, 51.0%, in 2000.
Serbia ranks 3rd of 184 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 5-14, female in Serbia, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 51.0% | — |
| 2010 | 81.7% | +60.1% |
| 2015 | 62.2% | -23.8% |
| 2019 | 67.0% | +7.7% |
| 2020 | 71.5% | +6.6% |
| 2021 | 83.2% | +16.4% |
Serbia compared with similar countries
- Serbia's 83.2% is above the median for upper middle income countries, which is 39.9%, 2.1× the median. (55 countries reporting)
- Serbia's 83.2% is above the median for Europe & Central Asia, which is 60.6%, 1.4× the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 51.0% | 51.0% | 51.0% | 1 |
| 2010s | 70.3% | 62.2% | 81.7% | 3 |
| 2020s | 77.3% | 71.5% | 83.2% | 2 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.022 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Serbia?
- Cause of death, by non-communicable diseases, ages 5-14, female in Serbia was 83.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Serbia?
- The highest recorded value was 83.2% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Serbia?
- The lowest recorded value was 51.0% in 2000.
- How does Serbia rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Serbia ranks 3rd out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Serbia?
- Over the last ten years it is up 1.8%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.